Last reviewed · How we verify
Absence epilepsy medications — Competitive Intelligence Brief
phase 3
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Absence epilepsy medications (Absence epilepsy medications) — Johns Hopkins University. Absence epilepsy medications work by reducing abnormal electrical activity in the brain that causes brief lapses in consciousness characteristic of absence seizures.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Absence epilepsy medications TARGET | Absence epilepsy medications | Johns Hopkins University | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Absence epilepsy medications CI watch — RSS
- Absence epilepsy medications CI watch — Atom
- Absence epilepsy medications CI watch — JSON
- Absence epilepsy medications alone — RSS
Cite this brief
Drug Landscape (2026). Absence epilepsy medications — Competitive Intelligence Brief. https://druglandscape.com/ci/absence-epilepsy-medications. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab